Autoimmune disorders are common in myelodysplastic syndrome patients and confer an adverse impact on outcomes

In conclusion, AD are prevalent in MDS and CMML patients and have prognostic implications, especially in lower-risk MDS patients.
Source: Annals of Hematology - Category: Hematology Source Type: research